Study of AMV564 in Subjects With Advanced Solid Tumors
NCT04128423
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Locally Advanced or Metastatic Solid Tumors
Interventions
BIOLOGICAL:
AMV564
Sponsor
Amphivena Therapeutics, Inc.